AnteoTech Ltd (AU:ADO)
ASX:ADO
Want to see AU:ADO full AI Analyst Report?
ADO Stock Chart & Stats
AU$0.02
>-AU$0.01(-5.00%)
At close: 4:00 PM EST
AU$0.02
>-AU$0.01(-5.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.05
Previous CloseN/A
Volume1.67M
Average Volume (3M)1.47M
Market Cap
AU$98.93M
Enterprise ValueAU$114.39M
Total Cash (Recent Filing)AU$1.44M
Total Debt (Recent Filing)AU$2.85M
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding3,091,465,000
10 Day Avg. Volume1,501,441
30 Day Avg. Volume1,471,917
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)10.79
Price to Sales (P/S)35.07
P/FCF Ratio-5.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.01
Revenue Forecast (FY)AU$1.70M
Bulls Say, Bears Say
Bulls Say
Proprietary Surface-chemistry PlatformAnteoTech's proprietary surface-functionalisation technology is a platform applicable to diagnostics and battery materials. As a platform, it can be embedded by partners, enabling licensing, product sales and recurring revenue streams as customers validate and adopt the tech over time.
Diversified Commercialization Revenue ModelThe company's mix of product sales, technology licensing, paid development services and grant/collaboration funding reduces single-source concentration risk. Multiple monetization channels improve the odds of steady revenue as partner validations and scale-up occur.
Manageable Balance-sheet LeverageA debt-to-equity of ~0.62 indicates moderate leverage and preserves financial flexibility for continued R&D and commercialization. Manageable debt reduces near-term refinancing pressure and supports continued investment while the company pursues partner-led revenue growth.
Bears Say
Persistent Losses And Negative MarginsConsistent negative net, EBIT and EBITDA margins reflect structural unprofitability. Ongoing losses limit the firm's ability to self-fund commercialization and scale, increase reliance on external capital, and raise execution risk if revenue ramps don't materialize within several quarters.
Negative Operating And Free Cash FlowNegative operating and free cash flows indicate the business is burning cash to support operations and development. Continued cash burn constrains strategic investments, heightens funding dependency, and risks dilution or curtailed initiatives if external financing is limited.
High Revenue Volatility And Steep Recent DeclineSharp revenue swings and a steep recent decline hamper forecasting and partner confidence. Erratic top-line trends make it harder to achieve manufacturing scale, secure long-term licensing, and plan margin recovery, increasing the likelihood of funding pressure during execution.
AnteoTech Ltd News
ADO FAQ
What was AnteoTech Ltd’s price range in the past 12 months?
AnteoTech Ltd lowest share price was <AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is AnteoTech Ltd’s market cap?
AnteoTech Ltd’s market cap is AU$98.93M.
When is AnteoTech Ltd’s upcoming earnings report date?
AnteoTech Ltd’s upcoming earnings report date is Sep 01, 2026 which is in 89 days.
How were AnteoTech Ltd’s earnings last quarter?
AnteoTech Ltd released its earnings results on Feb 24, 2026. The company reported AU$0 earnings per share for the quarter, the consensus estimate of N/A by AU$0.
Is AnteoTech Ltd overvalued?
According to Wall Street analysts AnteoTech Ltd’s price is currently Overvalued.
Does AnteoTech Ltd pay dividends?
AnteoTech Ltd does not currently pay dividends.
What is AnteoTech Ltd’s EPS estimate?
AnteoTech Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AnteoTech Ltd have?
AnteoTech Ltd has 3,091,465,000 shares outstanding.
What happened to AnteoTech Ltd’s price movement after its last earnings report?
AnteoTech Ltd reported an EPS of AU$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of AnteoTech Ltd?
Currently, no hedge funds are holding shares in AU:ADO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AnteoTech Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ADO Sentiment 95%
Sector Average ―
Sector Average ―
News Sentiment
Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.00%
12-Months-Change
Fundamentals
Return on Equity
-142.30%
Trailing 12-Months
Asset Growth
-58.00%
Trailing 12-Months
Company Description
AnteoTech Ltd
AnteoTech Limited, a surface chemistry company, develops, commercializes, manufactures, and distributes products for the life sciences, diagnostics, energy, and medical device markets primarily in Australia. Its products include AnteoBind ready-to-use kits to streamline and enhance the conjugation process; AnteoX, an additive that reinforces battery binders helping maximize performance of silicon containing anodes; EuGeni, a COVID-19 antigen rapid test; and AnteoRelease and AnteoCoat. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
Technical Analysis
Cynata Therapeutics Limited
―
Prescient Therapeutics Limited
―
Starpharma Holdings Limited
―
Avecho Biotechnology Limited
―
Proteomics International Laboratories Ltd.
―